Climb Bio Inc CLYM Advances 3 as Biotech Momentum Builds Cambium Networks CMBM Holds Steady at 040 as Stock Tests Key Resistance Vistagen Therapeutics VTGN Approaches Key Support After Marginal Decline Cadrenal Therapeutics CVKD Holds Steady Above Support as Traders Eye Resistance at 545 Childrens Place PLCE Rebounds 35 as ShortTerm Support Holds